Flow cytometry technology developer FlowMetric Life Sciences announced today that it launched a COVID-19 antibody test. Doylestown, Pa.-based FlowMetric’s antibody test provides greater than 99% specificity and 99% sensitivity more than 14 days after COVID-19 symptoms appear, according to a news release. The diagnostic is also touted as capable of differentiating an infection due to […]